Structure-activity studies reveal scope for optimisation of Ebselen-type inhibition of SARS-COV-2 main protease

<p>The reactive organoselenium compound ebselen is being investigated for treatment of coronavirus disease 2019 (COVID-19) and other diseases. We report structure-activity studies on sulfur analogues of ebselen with the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) main protease...

詳細記述

書誌詳細
主要な著者: Thun-Hohenstein, STD, Suits, TF, Malla, TR, Tumber, A, Brewitz, L, Choudhry, H, Salah, E, Schofield, CJ
フォーマット: Journal article
言語:English
出版事項: Wiley 2021